Quantum Biopharma (QNTM) Receivables (2018 - 2026)
Quantum Biopharma (QNTM) posted Receivables of $215,268 for Q2 2026, down 44.3% from $386,396 a year earlier and down 48.4% from the prior quarter.
Powered by 
Analysis
Quantum Biopharma (QNTM) Receivables (2018 - 2026) Analysis & Trends
At the end of FY2025, Quantum Biopharma's Receivables came in at $462,106, down 38.3% from FY2024.
- Annual Receivables shows a five-year compound annual growth rate of 7.4% (FY2020 to FY2025).
- In prior years, Quantum Biopharma's Receivables was $749,356 in FY2024 (+63.8%), $457,528 in FY2023 (-38.9%), $748,754 in FY2022 (-25.3%) and $1 million in FY2021 (+210.5%).
- Quarterly Receivables has run from a low of $156,600 in Q3 2025 to a high of $787,686 in Q1 2025 over five years.
- On a year-over-year basis, Receivables has declined in each of the last four quarters, with an average decline of 3.0% over the last seven quarters.
- The strongest year-over-year quarter for Receivables in the past five years was Q4 2021, with growth of 166.5%; the weakest was Q2 2024, with a decline of 71.0%.
- According to Business Quant data, Receivables for the three prior quarters was $417,048 (Q1 2026), $462,106 (Q4 2025) and $156,600 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Quantum Biopharma | 7.89 Mn | -2.45 Mn | - | 215,268.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 215,268.00 |
| Mar 31, 2026 | 417,048.00 |
| Dec 31, 2025 | 462,106.00 |
| Sep 30, 2025 | 156,600.00 |
| Jun 30, 2025 | 386,396.00 |
| Mar 31, 2025 | 787,686.00 |
| Dec 31, 2024 | 749,356.00 |
| Sep 30, 2024 | 208,408.00 |
| Jun 30, 2024 | 173,736.00 |
| Dec 31, 2023 | 457,528.00 |
| Dec 31, 2022 | 748,754.00 |
| Dec 31, 2021 | 500,964.00 |
| Dec 31, 2020 | 187,967.00 |
| Mar 31, 2020 | 1.37 Mn |
| Dec 31, 2019 | 1.60 Mn |
| Dec 31, 2018 | 727,490.83 |
API Access
Quantum Biopharma Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=QNTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "QNTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=QNTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();